Results 111 to 120 of about 19,375 (225)
Headliners: Uterine Leiomyoma: Genetic Reprogramming and Benign Uterine Tumors-0
, 2011 Copyright information:Taken from "Headliners: Uterine Leiomyoma: Genetic Reprogramming and Benign Uterine Tumors"Environmental Health Perspectives 2005;113(11):A740-A740.Published online Jan 2005PMCID:PMC1310945.This is an Open Access article: verbatim ...
Jerry Phelps (21429)
core +1 more source
MACROGLOBULIN PROTEINS IN ADENOMYOSIS AND UTERINE LEIOMYOMA
, 2015 We studied blood contents of alpha-2-macroglobulin (α2-MG), pregnancy-associated alpha2-glycoprotein (PAG), and their immune complexes with IgG in healthy female controls, as well as in women with adenomyosis, females with uterine myoma (with or without ...
N. V. Promzeleva +5 more
core +1 more source
Carotid intima-media thickness:. a new marker of patients with uterine leiomyoma
, 2014 Objective: To determine whether or not there are any significant differences in carotid intima-media thickness between patients with uterine leiomyoma and controls. Study Design: Patients whose ages were between 40 and 50 years, with body mass index
Sayin, Cenk +4 more
core +1 more source
UTERINE LEIOMYOMA: CLINICAL MANIFESTATIONS AND PERCEIVED IMPACT ON WOMEN’S HEALTH LIFE
, 2023 Objectives: Uterine leiomyoma/uterine fibroid is the benign tumor of the smooth muscle of the uterus. This study was conducted to identify the clinical features and the effects on their quality of life factors with the occurrence of uterine fibroids ...
THAMPI, AISWARYA +5 more
core
ENDOVASCULAR HEMOSTASIS IN UTERINE BLEEDING IN PATIENTS WITH UTERINE LEIOMYOMA
, 2017 We report results of treatment for 72 patients with uterine leiomyoma (LM) of various sizes and location, who had arrived with excessive uterine bleeding.
M. M. Damirov +5 more
core +1 more source
Mifepristone for preoperative treatment of uterine leiomyoma
, 2011 AIM: To explore the clinical impact and its molecular regulation on uterine leiomyomas in preoperative treatment with mifepristone, a progesterone receptor modulator (PRM).BACKGROUND: Uterine leiomyomas are highly prevalent in fertile women, increasing ...
Mikael Engman (18674752)
core
Frontiers in OncologyBackgroundParasitic leiomyoma is a rare subtype of uterine leiomyoma located outside the uterus, often deriving its blood supply from adjacent organs. With the popularization of laparoscopic surgery, reports of iatrogenic parasitic leiomyoma (IPL) as a ...
Shangqin Lin +4 more
doaj +1 more source
, 2013 Unexpected diagnosis of leiomyoma variants, atypia, or malignancy following morcellation performed at BWH for clinically presumed uterine leiomyoma.
Michael A. Seidman (267825) +5 more
core +1 more source
Management of Uterine Leiomyoma
, 2012 Background : To determine the prevalence ofclinically significant myomas and review varioustreatment options of uterine leiomyomas.Methods: In this cross-sectional study patientsadmitted for abnormal uterine bleeding, due to fibroids,were included in the
Sobia Nawaz Malik, Jehan Ara, Maliha Sadaf
core